Company Active LTD

Company profile

Decently Limited

UK company 13604268, incorporated on 6 September 2021.

Decently

Decently Limited is a UK company with status active founded in 2021.

Company number
13604268
Incorporated
6 Sep 2021
Companies House status
Active

Company identity

Founded / incorporated
6 September 2021

Company number 13604268

Verify at Companies House
Legal name
DECENTLY LIMITED
Company type
LTD
Region
Unknown
Registered address
Unknown
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
4

Company events

Reference milestones and recent Companies House filing stream events.

6 events
14 Jul
2026

Resolution

Resolution

RESOLUTIONS | Transaction WUY1UUtXRFZhZGlxemtjeA | Paper/PDF filed

Published 16 Jul 2026 00:52

07 Jul
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzUzMTAyNzcxOWFkaXF6a2N4

Published 07 Jul 2026 15:38

07 Jul
2026

Notification Of A Person With Significant Control

Persons-with-significant-control

PSC02 | Transaction MzUzMDk2ODAxOWFkaXF6a2N4

Published 07 Jul 2026 09:57

06 Jul
2026

Cessation Of A Person With Significant Control

Persons-with-significant-control

PSC07 | Transaction MzUzMDc1ODUwNGFkaXF6a2N4

Published 06 Jul 2026 15:25

06 Jul
2026

Cessation Of A Person With Significant Control

Persons-with-significant-control

PSC07 | Transaction MzUzMDc1ODM2OGFkaXF6a2N4

Published 06 Jul 2026 15:25

06 Sep
2021

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2022
Funded years
2022, 2026
Age at first award
1 years

Projects

2026 Collaborative R&D Lead participant

Melo - an innovative AI digital health platform to assess behaviour in patients with brain injuries, decreasing assessment time and delivering organisational cost savings across West Yorkshire

1 Jul 2026 to 30 Jun 2027

Awarded
£366,798
Total cost £523,997

Challenging-to-manage behaviours (CtMB) are prevalent in 30-70% of patients with traumatic brain injury (TBI), significantly affecting recovery and increasing healthcare costs. TBI impacts approximately 55 million people globally, costing over £350 billion annually. CtMB can extend hospital stays by about 19 days, leading to inefficiencies and increased s...

2022 Grant for R&D Lead participant

Melo - use of AI and predictive analytics to help address violent behaviours in mental health patient groups

1 Nov 2022 to 30 Apr 2023

Awarded
£50,000
Total cost £50,000

**_Melo_** is a new digital health app designed to help doctors and nurses across the UK provide better, more pro-active care for some of our most vulnerable mental health patient groups. For these patients, challenging behaviours (and violent outbursts) can be an ongoing challenge. Managing and dealing with this is an equally big challenge for those who ...

Product types

Collaborative R&D Grant for R&D